AWARENESS
Understanding Endometriosis
What misconceptions plague the disease? How do you navigate the current medical systems?
Myths vs. Reality
The Myth: Endometriosis is just a heavy period.
Scientific Fact: It is a complex systemic disease involving endometrial-like tissue growing outside the uterus, causing chronic pain, inflammation, and potential organ dysfunction.
The Myth: Pregnancy cures endometriosis.
Scientific Fact: Pregnancy may temporarily suppress symptoms due to hormonal changes, but it is not a cure. Lesions often persist or reappear post-partum.
The Myth: Hysterectomy is the definitive cure.
Scientific Fact: Since the disease exists outside the uterus, removing the uterus does not guarantee the removal of all endometriotic lesions, which can continue to grow.
The Myth: It only affects the reproductive system.
Scientific Fact: Whilst infertility is a common sympton, endometriosis is a multi-system chronic inflammatory condition that can affect the bowel, bladder, and in rare cases, even the lungs or brain.
Overcoming the Barriers
The path to therapeutic breakthroughs in endometriosis is complex. We identify and address the fundamental obstacles that have historically stalled clinical progress and diagnostic innovation.
Structural Heterogeneity
The diverse nature of endometriotic lesions across patients makes standardized treatment difficult. Our research focuses on identifying universal ECM signatures to overcome this variability.
Developmental Latency
The significant delay between symptoms and diagnosis impedes research into early-stage disease. We are developing tools for earlier detection using high-resolution ECM imaging.
Translational Gap - the problems in the clinic
Moving discoveries from the lab bench to clinical trials requires robust models that mimic the human diseased niche. Our PathECM platform aims to bridge this gap directly.
Then the right clinical outcomes need to be available to test whether a drug works. We are working with the rest of the field to understadn what may be the best outcomes to use.
A New Era of Discovery
A changed funding landscape
Targeted Therapy
Unified Advocacy
Recent reports by the Milken Institute, World Economic Forum and beyond have made a strong financial case for why caring about women's health is good for business, which has helped massively expand the funding currently going into these innovations.
The shift from general symptom management to precision medicine target-based approaches is accelerating the development of drugs that reverse fibrosis in human tissue.
Global collaborations between patients and scientists are dismantling legacy barriers, ensuring that research funding directly supports clinical breakthroughs for 1 in 10 women.